(SECARE) Swedencare publ - Ratings and Ratios

Swedencare AB (publ) is a leading global player in the animal healthcare industry, providing a diverse range of products for cats, dogs, and horses across North America, Europe, and other international markets. The companys product portfolio is comprehensive, encompassing animal nutritional supplements, treats, grooming products, and pharmaceutical-grade health products under various brand names, including Healthy Breeds, Innovet, Stratford Animal Health, NaturVet, and others.

The companys brands cater to different therapeutic areas, such as orthopedics, behavior, dermatology, and gastroenterology, offering pet owners and veterinarians a range of solutions for various pet health issues. Swedencares products are distributed through multiple channels, including veterinarians, pet stores, and online platforms, ensuring wide accessibility. With a history dating back to 1993, the company has established itself as a significant player in the animal healthcare sector, headquartered in Malmö, Sweden.

Analyzing the companys technical data, the stocks current price is 42.00 SEK, with a 20-day simple moving average (SMA) of 40.48 SEK, indicating a positive trend. The 50-day SMA is 38.46 SEK, further supporting the uptrend. However, the 200-day SMA is 43.16 SEK, suggesting that the stock may be experiencing a minor correction. The average true range (ATR) is 1.59, equivalent to 3.80%, indicating moderate volatility.

From a fundamental perspective, Swedencares market capitalization stands at 6402.18M SEK, with a price-to-earnings (P/E) ratio of 68.31 and a forward P/E of 28.65. The return on equity (RoE) is 1.22, indicating that the company is generating returns, albeit modest ones. Considering the P/E ratio and the companys growth prospects, it is likely that the stock will experience a correction towards the mean P/E ratio for the biotechnology sub-industry.

Based on the technical and fundamental data, a forecast for Swedencare AB (publ) can be made. Given the current uptrend and the companys solid product portfolio, it is likely that the stock will continue to rise in the short term. However, the high P/E ratio and moderate RoE may lead to a correction in the long term. A potential target price could be around 50-55 SEK, representing a 15-20% increase from the current price. Nevertheless, investors should be cautious of the potential correction and monitor the companys future earnings reports and industry trends.